TY - JOUR
T1 - Serum levels of neurotrophic factors in active toxoplasmic retinochoroiditis
AU - Cordeiro, Cynthia Azeredo
AU - Vieira, Erica Leandro Marciano
AU - Rocha, Natália Pessoa
AU - Castro, Vinicius Monteiro
AU - Oréfice, Juliana Lambert
AU - Barichello, Tatiana
AU - Costa, Rogerio Alves
AU - Oréfice, Fernando
AU - Young, Lucy
AU - Teixeira, Antonio Lucio
N1 - Publisher Copyright:
© 2016 Sociedade Brasileira de Infectologia
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Toxoplasmic retinochoroiditis (TR) is the most common identifiable cause of posterior uveitis in Brazil. Response to treatment and clinical presentation may vary significantly. We assessed serum levels of brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), neurotrophin (NT)-3, and NT-4/5 in patients with active TR, before and after TR treatment. Methods Twenty patients with active lesion and 15 healthy controls were enrolled in the study. Serum concentration of neurotrophic factors was determined by enzyme-linked immunosorbent assay. Results BDNF levels were significantly higher in patients before treatment when compared with controls (p = 0.0015). There was no significant difference in pro-BDNF, NGF, GDNF, NT-3, and NT-4/5 levels between TR patients and controls. Treatment did not affect the levels of these factors. Conclusion BDNF may be released in the context of the active TR inflammatory response.
AB - Toxoplasmic retinochoroiditis (TR) is the most common identifiable cause of posterior uveitis in Brazil. Response to treatment and clinical presentation may vary significantly. We assessed serum levels of brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), neurotrophin (NT)-3, and NT-4/5 in patients with active TR, before and after TR treatment. Methods Twenty patients with active lesion and 15 healthy controls were enrolled in the study. Serum concentration of neurotrophic factors was determined by enzyme-linked immunosorbent assay. Results BDNF levels were significantly higher in patients before treatment when compared with controls (p = 0.0015). There was no significant difference in pro-BDNF, NGF, GDNF, NT-3, and NT-4/5 levels between TR patients and controls. Treatment did not affect the levels of these factors. Conclusion BDNF may be released in the context of the active TR inflammatory response.
KW - Brain-derived neurotrophic factor
KW - Retinochoroiditis
KW - Toxoplasma gondii
UR - http://www.scopus.com/inward/record.url?scp=85008385054&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85008385054&partnerID=8YFLogxK
U2 - 10.1016/j.bjid.2016.11.005
DO - 10.1016/j.bjid.2016.11.005
M3 - Article
C2 - 27932287
AN - SCOPUS:85008385054
SN - 1413-8670
VL - 21
SP - 176
EP - 179
JO - Brazilian Journal of Infectious Diseases
JF - Brazilian Journal of Infectious Diseases
IS - 2
ER -